Cardiac Effects Associated With Breast Cancer Treatment Appear Lower

A new pilot study by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a “dose-dense” regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown to cause cardiac toxicity.

More: continued here

Filed under: Breast Cancer on March 14th, 2008